Clinical Trial Update: Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating veliparib with carboplatin and paclitaxel in adults with advanced solid tumors has completed. The study included BRCA mutation carriers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome
• Ovarian Cancer
• Solid Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Solid Neoplasm, BRCA1 Mutation Carrier | Phase 1 | Status: COMPLETED